维普中文期刊产品整合服务
277篇 您的检索式:作者名="TRIGO"
    题名 作者 年代 出处 被引量
1Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis显示文摘AIM: To assess the usefulness of urinary trypsinogen-2 test strip, urinary trypsinogen activation peptide (TAP),and serum and urine concentrations of the activation peptide of carboxypeptidase B (CAPAP) in the diagnosisof acute pancreatitis.METHODS: Patients with acute abdominal pain and hospitalized within 24 h after the onset of symptoms were prospectively studied. Urinary trypsinogen-2 was considered positive when a clear blue line was observed (detection limit 50 μg/L). Urinary TAP was measured using a quantitative solid-phase ELISA, and serum and urinary CAPAP by a radioimmunoassay method.RESULTS: Acute abdominal pain was due to acute pancreatitis in 50 patients and turned out to be extrapancreatic in origin in 22 patients. Patients with acute pancreatitis showed significantly higher median levels of serum and urinary CAPAP levels, as well as amylase and lipase than extrapancreatic controls. Median TAP levels were similar in both groups. The urinary trypsinogen-2 test strip was positive in 68% of patients with acute pancreatitis and 13.6% in extrapancreatic controls (P<0.01). Urinary CAPAP was the most reliable test for the diagnosis of acute pancreatitis (sensitivity 66.7%, specificity 95.5%, positive and negative predictive values 96.6% and 56.7%, respectively), with a 14.6 positive likelihood ratio for a cut-off value of 2.32 nmol/L.CONCLUSION: In patients with acute abdominal pain,hospitalized within 24 h of symptom onset, CAPAP in serum and urine was a reliable diagnostic marker of acute pancreatitis. Urinary trypsinogen-2 test strip showed a clinical value similar to amylase and lipase.Urinary TAP was not a useful screening test for the diagnosis of acute pancreatitis.Jesús Sáez Juan Martínez Celia Trigo José Sánchez-Payá Luis Compay Raquel Laveda Pilar Grió Cristina García Miguel Pérez-Mateo 2005World Journal of Gastroenterology2005,11,46:21
2Coronary angiography findings in cardiac arrest patients with non-diagnostic post-resuscitation electrocardiogram:A comparison of shockable and non-shockable initial rhythms显示文摘AIM To investigate the impact of coronary artery disease in a cohort of patients resuscitated from cardiac arrest with non-diagnostic electrocardiogram.METHODS From March 2004 to February 2016, 203 consecutive patients resuscitated from in or out-of-hospital sudden cardiac arrest and non-diagnostic post-resuscitation electrocardiogram(defined as ST segment elevation or pre-sumably new left bundle branch block) whounderwent invasive coronary angiogram during hospitalization were included. For purpose of analysis and comparison, patients were classified in two groups: Initial shockable rhythm(ventricular tachycardia or ventricular fibrillation; n = 148, 72.9%) and initial non-shockable rhythm(n = 55, 27.1%). Baseline characteristics, coronary angiogram findings including Syntax Score and long-term survival rates were compared. RESULTS Sudden cardiac arrest was witnessed in 95.2% of cases, 66.7% were out-of-hospital patients and 72.4% were male. There were no significant differences in baseline characteristics between groups except for higher mean age(68.1 years vs 61 years, P = 0.001) in the nonshockable rhythm group. Overall 5-year mortality of the resuscitated patients was 37.4%. Patients with non-shockable rhythms had higher mortality(60% vs 29.1%, P < 0.001) and a worst neurological status at hospital discharge based on cerebral performance category score(CPC 1-2: 32.7% vs 53.4%, P = 0.02). Although there were no significant differences in global burden of coronary artery disease defined by Syntax Score(mean Syntax Score: 10.2 vs 10.3, P = 0.96) there was a trend towards a higher incidence of acute coronary lesions in patients with shockable rhythm(29.7% vs 16.4%, P = 0.054). There was also a higher need for ad-hoc percutaneous coronary intervention in this group(21.9% vs 9.1%, P = 0.03). CONCLUSION Initial shockable group of patients had a trend towards higher incidence of acute coronary lesions and higher need of ad-hoc percutaneous intervention vs nonshockable group.Pedro Martínez-Losas Pablo Salinas Carlos Ferrera María Teresa Nogales-Romo Francisco Noriega María Del Trigo Iván Javier Núnez-Gil Luis Nombela-Franco Nieves Gonzalo Pilar Jiménez-Quevedo Javier Escaned Antonio Fernández-Ortiz Carlos Macaya Ana Viana-Tejedor 2017World Journal of Cardiology2017,9,8:3
3Start-up of the Anammox process in a membrane bioreactor显示文摘C. Trigo J.L. Campos J.M. Garrido R. Méndez 2006Journal of Biotechnology2006,,4:2
4The AOR iterative method for new preconditioned linear systems显示文摘Evans D J Martimns M M Trigo M E 2001J Comput Appl Math2001,132,2:1
5A multicenter phase Ⅱ trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patientswith previously treated metastatic breast cancer 显示文摘MILLER K D TRIGO J M WHEELER C 2005Clin Cancer Res2005,11,9:1
6Irrsdiation effect on fatty acid composition and conjugated linoleic acid isomers in frozen lamb meat显示文摘Cristina MM Alfaia Paulo JLC Riberiro Mafia JP Trigo 2007Meat Science2007,77,:1
7Phase II mulitcenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck显示文摘Baselga J Trigo JM Bourhis J 2005J Clin Oncol2005,23,:1
8Immunohistochemical Detection of Antigensof Distemper, Adenovirus and Parainfluenza Virusesin Domestic Dogs with Pneumonia显示文摘Damian M Morales E Salas G Trigo FJ 2005J Comp Path2005,133,4:1
9Cetuximab: monotherapy is active in patient s ( pts ) with platinum refractory recurrent /metastatic squamous cell carcinoma of the head and neck (SCCHN) : results of a Phase Ⅱ study 显示文摘Trigo J Hitt R Koralewski P 2004Proc Am Soc Clin Oncol2004,23,:1
10Maize and resistant starch enriched breads reduce postprandial glycemic responses in rats显示文摘Carla M. Brites Maria J. Trigo Belmira Carrapi?o Marcela Alvi?a Rui J. Bessa 2011Nutrition Research2011,,4:1
11Evaluation of Prognostic Factors for Early Infection in Liver Transplantation显示文摘Cueto G Trigo P Arata A 1999Transplant Proc1999,31,7:1
12Psychosocial risk factors in coronary heart disease:beyond type A behavior显示文摘Trigo M Silva D Rocha E 2005Rev Port Cardiol2005,24,2:1
13Evaluation of the effi- cacy of deep brain stimulation in the surgical treatment of cervical dystonia显示文摘Calheiros --Trigo F Linhares P 2014Neurocirugia2014,,2:1
14Cetuximab (C225) plus cisplatin/carboplatin is active in patients (pts) with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) progressing on a same dose and schedule platinum based agent显示文摘Baselga J Trigo JM Bourthis J 2002Proc Am Soc Clin Oncol2002,21,22:1
15Activity of glycolytic enzymes in the gut of Hormogaster elisae(Oligechaeta Hormogastridae)显示文摘GARVIN M H LATTAUD C TRIGO D 2000Soil Biology & Biochemistry2000,,32:1
16Open-label,uncontrolled,multicenter phase Ⅱ study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum based therapy显示文摘Vermorken JB Trigo J Hitt R 2007J Clin Oncol2007,25,16:1
17A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes显示文摘Trigo Rocha F Gomes CM Mitre AI 2008Urology2008,71,1:1
18Cell signalling of the GLP-1 action in rat liver显示文摘Redondo A Trigo M V Acitores A 2003Mol Cell Endocrinol2003,204,12:1
19Simplified modu- lated evaporation process for the production of CulnS2 films with reduced substrate temperatures 显示文摘Bollero A Trigo J F Herrero J 2009Thin Solid Films2009,517,7:1
20Respiratory Therapy 显示文摘Gtiell Rous MR DIaz Lobato S Rodriguez Trigo G 2014Arch Bronconeumol2014,2,14:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费